Monoamine Oxidase Inhibition by Kavalactones from Kava (Piper Methysticum).

Denise Prinsloo, Sandra van Dyk, Anél Petzer, Jacobus P Petzer

Journal: Planta medica 2019;85(14-15):1136-1142

PMID: 31539917

Abstract

Monoamine oxidases (MAOs) are key metabolic enzymes for neurotransmitter and dietary amines and are targets for the treatment of neuropsychiatric and neurodegenerative disorders. This study examined the MAO inhibition potential of kavain and other kavalactones from the roots of kava (), a plant that has been used for its anxiolytic properties. (±)-Kavain was found to be a good potency inhibitor of human MAO-B with an IC of 5.34 µM. (±)-Kavain is a weaker MAO-A inhibitor with an IC of 19.0 µM. Under the same experimental conditions, the reference MAO inhibitor, curcumin, displays IC values of 5.01 µM and 2.55 µM for the inhibition of MAO-A and MAO-B, respectively. It was further established that (±)-kavain interacts reversibly and competitively with MAO-A and MAO-B with enzyme-inhibitor dissociation constants (K) of 7.72 and 5.10 µM, respectively. Curcumin in turn, displays a K value of 3.08 µM for the inhibition of MAO-A. Based on these findings, other kavalactones (dihydrokavain, methysticin, dihydromethysticin, yangonin, and desmethoxyyangonin) were also evaluated as MAO inhibitors in this study. Yangonin proved to be the most potent MAO inhibitor with IC values of 1.29 and 0.085 µM for MAO-A and MAO-B, respectively. It may be concluded that some of the central effects (e.g., anxiolytic) of kava may be mediated by MAO inhibition.

Georg Thieme Verlag KG Stuttgart · New York.

Address: Pharmaceutical Chemistry, School of Pharmacy and Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.